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ABSTRACT 
The post-surgical period is often critical for infection acquisition. The combination of patient injury and environmental exposure through breached skin add risk to 
pre-existing conditions such as drug or depressed immunity. Several factors such as the period of hospital staying after surgery, base disease, age, immune 
system condition, hygiene policies, careless prophylactic drug administration and physical conditions of the healthcare centre may contribute to the acquisition 
of a nosocomial infection. A purulent wound can become complicated whenever antimicrobial therapy becomes compromised. In this pilot study, we 
analysed Enterobacteriaceae strains, the most significant gram-negative rods that may occur in post-surgical skin and soft tissue infections (SSTI) 
presenting reduced β-lactam susceptibility and those presenting extended-spectrum β-lactamases (ESBL). There is little information in our country regarding 
the relationship between β-lactam susceptibility, ESBL and development of resistant strains of microorganisms in SSTI. Our main results indicate Escherichia coli 
and Klebsiella spp. are among the most frequent enterobacteria (46% and 30% respectively) with ESBL production in 72% of Enterobacteriaceae isolates 
from SSTI. Moreover, coinfection occurred extensively, mainly with Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus (18% and 13%, 
respectively). These results suggest future research to explore if and how these associations are involved in the development of antibiotic resistance. 
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Key Points 
• when  the  skin  is  compromised infection may occur 
• several   microorganisms   were 
found     among     post-surgical wounds infections 
• we    analysed    the    infectious 
gram-negative   rods   found   in post-surgical   wounds   for   the presence of extended-spectrum β-lactamases (ESBLs) 
• ESBLs    are    plasmid-encoded 
enzymes that confer resistance to     penicillins,     cefalosporins (up    to    fourth    generation), cephamycins and aztreonam 
• ESBLs are encoded to plasmids 
that   may   also   confer   resis- tance  to  aminoglycosides  and quinolones 
• among  the  enterobacteria  iso- 
lates  we  have  found  70%  of ESBL-producers   in   two   Por- tuguese hospitals with different genotypic  and  phenotypic  pro- files 
• the post-surgical wounds were 
also    coinfected    with    Pseu- domonas aeruginosa (18% inci- dence) and Methicillin-resistant Staphylococcus  aureus  (MRSA) (13% incidence) 
• if   further   research   identifies 
a  causal  relationship  between ESBL production and the devel- opment of antibiotic resistance in  microorganisms,  these  find- ings may help provide the basis for nationwide strategies 
to pre- vent drug resistance 
 
 
 
 
 
 
 
INTRODUCTION 
Wound is any physical damage to the body that exposes subcutaneous tissue (1). When the skin, the primary barrier between 
the environ- ment and the human body, is compromised, infection may occur (2). Damage to the skin tis- sue is because of any 
physical trauma or injury that may be accidental or intentional. Med- ical procedures often induce skin continuity loss in smaller 
(intravenous medical   devices) 
 
  
 
 
or greater extension (surgery). Hospitals are 
although important environments that may 
lead to the development of an infection. 
Although not intentionally induced, hospital- 
acquired wounds can also be because of the 
local ischemia caused by the pressure of the 
body on the bed surface, referred as decu- 
bitus or pressure ulcers. When such wounds 
become infected, they are often colonised by 
multiple bacterial species. Many studies refer 
staphylococci members as among the most 
prevalent agents found in skin and  soft tis- 
sue infections (SSTI) along with enterococci, 
streptococci and gram-negative members (3). 
The prevalence of multidrug resistance (MDR) 
continues to increase among many pathogens 
largely because of overuse and misuse of 
antimicrobial agents (1). Such use not only 
adds to the cost of medical care, but also need- 
lessly exposes the patient to potential toxicity 
and risks that promote the development and 
spread of antimicrobial resistance in healthcare 
facilities (4). 
Antimicrobial resistance is a major contem- 
porary issue (5). Mechanisms underlying the 
development of drug resistance are complex 
and varied. One example is the antimicrobial 
target modification exhibited by Staphylococ- 
cus aureus. Penicillin-binding proteins (PBP), 
the target for β-lactams, may be altered by 
mutation in S. aureus.  This  type  of  muta- 
tion are on the etiological course for the 
development of penicillin and other β-lactams 
resistance (6,7)   such   as  methicillin-resistant 
S. aureus (MRSA). Resistance to the β-lactams 
may also occur because of the acquisition of 
enzymatic machinery such as β-lactamases, 
especially the ESBL (6). Little epidemiologi- 
cal studies have focused on the  involvement 
of enterobacteria causing SSTI. In this study, 
the antimicrobial susceptibility of enterobac- 
teria as etiological agents in the SSTI, the 
prevalence of ESBL among these pathogens 
and the most common coinfections associ- 
ated in the SSTI in post-surgery complicated 
wounds in Portugal for a period  of  2 years 
are described. The β-lactamases (bla) genes, 
blaTEM , blaSHV  and  blaCTX−M  were screened 
by means of polymerase chain reaction (PCR) 
and sequencing methods; furthermore, it was 
also used a molecular fingerprinting technique 
designed for Enterobacteriaceae members 
using the enterobacterial repetitive  intragenic 
consensus (ERIC) sequences (8) in order to 
understand/establish genetic relations. 
 
 
MATERIALS AND METHODS 
Bacterial strains, identification 
and susceptibility 
All isolates had been provided from two 
Portuguese Clinical Pathology Laboratories; 
all patients with positive culture results of 
Enterobacteriaceae from surgical site infections 
and  that  include  of  the  following  findings: 
(a) purulent incisional drainage; (b) positive 
results of culture of aseptically obtained fluid 
or tissue from the superficial wound; (c) local 
signs and symptoms of pain or tenderness, 
swelling, and erythema, with the incision 
opened by the surgeon; strains were col- 
lected by swab and transported in the same 
day to the laboratory during the period 
comprised from September 2007 and August 
2009; bacterial identification and preliminary 
antimicrobial susceptibility were determined 
by a microdilution method using automated 
Vitek II (bioMe´rieux, Marcy-l’Etoile, France) 
system and double checked with the disc- 
diffusion methods according to the Clinical 
and Laboratory Standards Institute (CLSI; 
formerly the  National  Committee  of Clin- 
ical Laboratory Standards) guidelines (9,10) 
for minimum inhibitory concentration (MIC) 
determination. ESBL production was assessed 
with two Epsilometer test (E-test, AB Biodisk, 
Solna, Sweden) strips and confirmed as 
positive whenever a ≥ threefold-dilution 
difference between ceftazidime and cef- 
tazidime/clavulanic acid or/and ≥ threefold- 
dilution difference between cefotaxime and 
cefotaxime/clavulanic MICs according to the 
manufacturer  instructions. 
 
Conjugation experiments 
Transmissibility of resistance has been tested 
by matting clinical isolates to F− strains of 
azide-resistant E. coli J53 AziR on trypticase 
soy broth (TSB) according to (11). 
 
Analytical IEF 
Crude preparations of β-lactamases from 
clinical strains transconjugants were obtained 
by sonicating the cells in phosphate buffer, 
pH 7·0 (12). Then, 20 l of crude protein 
concentrated  extract  was  added  to  50 l   of 
  
 
 
nitrocefin (OXOID, Hampshire, UK) solution 
(50 mg/l in 1% glycine plus 50% glycerol). 
Samples converted from yellow to dark pink 
in 30 to 60 seconds; 10 l of each sample were 
run in precast isoelectric focusing (IEF) mini- 
gels, pH 3–10 (Bio-Rad, Milano, Italy), in a 
Mini-Protean II unit (Bio-Rad, Milano, Italy) 
according to the manufacturer instructions. 
 
Genetic molecular characterisation 
of bla genes and genetic profiling 
PCR primers were designed for blaTEM (Fw- 
ataaaattcttgaagacgaaa and Rv-cagttaccaatgctt 
aatca) (13), blaSHV (Fw-gccgggttattcttatttgtc and 
Rv-gctctttccgatgccgccgccagtca) (14), blaCTX−M1 
(Fw-atggttaaaaaatcactgcg and Rv-ttacaaaccgtc 
ggtgac) (15), blaCTX−M2 (Fw-atgatgactcagagcatt 
cg and Rv-ttattgcatcagaaaccgtg) (16) blaCTX−M9 
(Fw-gtgacaaagagagtgcaacgg and Rv-atgattctcg 
ccgctgaagcc) (17) and blaCTX−M8 and blaCTX−M25 
which share the same reverse primer (Rv- 
aacccacgatgtgggtagc) but have different for- 
ward primers (Fw8-tcgcgttaagcggatgatgc and 
Fw25-gcacgatgacattcggg) (18), and conditions 
were performed as described. PCR amplicons 
were run in 1·2% agarose (Bioron GmbH, 
Ludwigshafen, Germany) and bands were cut 
off from the gel and purified for subcloning. 
The recovered bands from agarose were sub- 
cloned in TOPO TA CloningTM kit (Invitro- 
gen Corporation, San Diego, CA) for further 
sequencing. The nucleotide sequences of both 
ends of the insert were determined with M13 
sequencing primers specific for the cloning vec- 
tor (19). Regarding molecular fingerprinting it 
was performed with PCR reaction according 
the description of Versalovic et al. (8) using the 
primers ERIC1R-atgttagctcctggggattcac and 
ERIC2-aagtaagtgactggggtgagcg. ERIC profiles 
were analysed with software, FPQuestver- 
sion 4·5, Fingerprinting II (Bio-Rad Laborato- 
ries, Hercules, CA, US). 
 
 
RESULTS AND DISCUSSION 
Ninety-seven enterobacteriae isolates har- 
vested during the 2-year period expressed 
resistance (MIC50 ≥ 16 g/ml) to at least to 
second generation cephalosporins. Escherichia 
coli  was  the  most   representative  member 
(n = 44; 46%) followed by Klebsiella pneumo- 
niae (n = 28; 29%) and then by Enterobacter 
aerogenes (n = 7; 7%), Morganella morganii (n = 
7; 7%), Enterobacter cloacae (n = 5; 4%), Serratia 
marcescens (n = 2; 2%), Citrobacter freundii (n = 
1; 1%), Klebsiella oxytoca (n = 1; 1%), Proteus 
vulgaris (n = 1; 1%)  and  Serratia liquefaciens 
(n = 1; 1%). These findings are in agreement 
with most of the studies that described that 
among post-surgical procedures, there is an 
increased risk to acquire a nosocomial infec- 
tion and, that among the gram-negative  rods, 
E. coli, Klebsiella spp. and Enterobacter spp. are 
the most frequent (3,20,21). 
MIC tests show that SSTI isolates were 
mostly resistant β-lactams. Concerning peni- 
cillins, they were 98% resistant to ampicillin 
and 89% resistant to amoxicillin/clavunate 
combination. Strains were also 100% resistant 
to all first and second generation cephalor- 
porins, including cefalotin, cefazolin, and both 
sodium-cefuroxime and axetil-cefuroxime, and 
presented high resistance levels to third and 
fourth generation cephalosporins. So, to cef- 
tazidime, SSTI isolates show 97% of resistance, 
88% to cefotaxime and 70% to the fourth 
generation cefepime. Nevertheless, regard- 
ing to carbapenems, these isolates present a 
general susceptibility to carbapenems, 100% 
to both imipenem and meropenem. The 
antimicrobial susceptibility pattern is vari- 
able among the aminoglycosides as SSTI iso- 
lates are 98% susceptible to  amikacin  and 
60% resistant to gentamicin. In what con- 
cerns to quinolones, they are 70% resistant to 
ciprofloxacin. Finally, as regards sulfonamides 
such as the trimethoprim-sulphametoxazole 
70% of the strains in the study presented a 
susceptibility pattern. 
As reported in previous Portuguese (22–25), 
Spanish (26,27) and other European (28) stud- 
ies, E. coli and K. pneumonia are the species 
where ESBL is the most frequently identified. 
In the present study from the 97 isolates 70 
(72%) carried an ESBL. Again, E. coli was the 
organism presenting ESBL more often (43/44; 
98%)  and  then  K.  pneumoniae  (24/28;  86%). 
E. aerogenes and K. oxytoca (n = 2 and n = 1, 
respectively) also produced ESBL. 
Regarding ESBL enzymes, the TEM type 
was the most frequent (29/70; 41%) followed 
by the CTX-M type (23/70; 33%) and finally 
the SHV type (18/70; 26%). Among TEM 
enzymes it was found the TEM-24, TEM-52, 
TEM-10 and TEM-116 varieties  (20%,  14%, 
6%  and  1%,  respectively).  CTX-M  type    is 
a heterogeneous group constituted by five 
phylogenetic  branches (29).  In  this  study   it 
  
 
 
was found representatives from two branches, 
the  CTX-M-1  and  CTX-M-9.  Members  of 
the CTX-M-1 group included the CTX-M-15 
and CTX-M-1 enzymes (13% and 3%, respec- 
tively). CTX-M-9 group was represented by 
CTX-M-9 and CTX-M-15 enzymes (10% and 
7% respectively). Finally in what concerns to 
the SHV enzymes it was found the SHV-5 and 
SHV-12 (14% and 12%, respectively). 
Coinfections were also relatively common 
among patients from which these isolates 
were   recovered.   Among   the   E.   coli    and 
K. pneumoniae isolates from  SSTI  it  was 
found other 91 microorganisms coinfecting 
the wounds (Figure 1). The most frequent 
coinfection microorganism was Pseudomonas 
aeruginosa (17/97; 18%) followed by S. aureus 
(15/97; 15%), E. coli (13/97; 13%), Klebsiella spp. 
(11/97; 11%), Enterobacter spp. (10/97; 10%) 
and Enterococcus faecalis (7/97; 7%). 
From staphylococci members coinfecting 
post-surgical wounds 87% (13/15) were MRSA 
and only 13% (2/15) were methicillin suscep- 
tible. A total of 46% (6/13) of E. coli isolates 
coinfecting  post-surgical  wounds  were  also 
ESBL positive but 54% (7/13) did not carried 
any β-lactamase. Similarly, in what concerns 
to Klebsiella spp. coinfecting post-operative 
wounds 45% (5/11) harbours another ESBL, 
whereas 55% (6/11) does not. 
In a single long-term patient it was pos- 
sible to isolate five ESBL-producing E.  coli 
and K. pneumoniae from different infection 
episodes. The patient,  a  51-year-old male, 
first developed a urinary-tract infection (UTI) 
in April 2005 caused by two distinct ESBL- 
producing E. coli; one of them harbouring a 
TEM-10 enzyme and the other a CTX-M-15. 
Later in May of the same year, the same patient 
developed a second UTI, and this time caused 
by an SHV-2 producing K. pneumoniae. One 
month later, in July, a pressure ulcer devel- 
oped possibly as a result of friction, pressure or 
sheer and became contaminated with a SHV-5 
producing K. pneumoniae. Finally, on Septem- 
ber of the same year, this patient experienced 
another UTI with the same SHV-5   producing 
K. pneumoniae (genetic similarity ≥90%) found 
first in the purulent wound (Figure 2). 
 
 
Figure 1. Occurrence of bacteria and yeast (Candida albicans) coinfecting skin and soft tissue infections (SSTI) caused by 
extended-spectrum β-lactamases (ESBL)-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae (white bars). The 
diagram shows the number (left side) of microorganism (right side) that occurred simultaneously with ESBL-producing E. coli (black 
bars) and with ESBL-producing K. pneumoniae (white bars). 
  
 
 
 
Figure 2. Enterobacterial repetitive intragenic consensus (ERIC) fingerprinting profiles of extended-spectrum β-lactamases (ESBL) 
producing Escherichia coli and Klebsiella pneumoniae isolated from a single patient from April to September of 2005. UTI stands for 
urinary-tract infection. SSTI stands for skin and soft tissue infections. Dendograms were generated by UPGMA analysis of the agarose 
gels using the FPQuest version 4.1.5 (Bio-Rad). 
 
In another long-term patient with an 
oncological issue, from another hospital, 
experienced a rarely described situation, an 
injury caused  by  radiotherapy.  This patient, 
a 55-year-old female, presented two SSTI 
episodes. The first one in August 2005 was 
caused  by  a   CTX-M-14   producing   E. coli. 
A few weeks later in September after apparent 
recovery the infection reappeared and became 
complicated with P. aeruginosa along the same 
CTX-M-14 producing E. coli (genetic similarity 
≥90%; data not shown) that was present in the 
first episode in August. 
Reduced susceptibility to formerly effec- 
tive antibiotics is increasing worldwide among 
the SSTI causing agents (3). This is most cer- 
tainly as a result of overuse, misuse  and 
abuse of antimicrobial agents’ sensu lato. 
Examples of abusive antimicrobial usage 
include the exaggerated prophylactic mea- 
sures, self-medication or even use of com- 
mercial product with antiseptic/antimicrobial 
agents and also the use for non human pur- 
poses such as in livestock production (5,30,31). 
Centers for Disease Control and Prevention 
(CDC) and policy makers are very committed 
to the implementation of educational strategies 
not only for health professional (32,33) but also 
for general population. 
In general, this pilot study in only two 
hospitals point to an important issue, that is 
the emergence of ESBL among gram-negative 
rods involved in nosocomial wounds in our 
country. These findings extend beyond the 
original purpose, of this study, suggesting 
exploration of interactions  between  ESBL 
and  development  of  antibiotic  resistance  in 
P. aeruginosa and gram-positive bacteria  such 
streptococci, enterococci and staphylococci 
with special attention to MRSA (34,35). 
In conclusion, the emergence of ESBL 
among gram-negative rods and possibly 
related antibiotic-resistant strains of other 
pathogens (35) merits further research and 
epidemiologic study as well as immediate 
development of policies monitor drug delivery 
in hospital and ambulatory pharmacies and 
the implementation of public health defence 
strategies towards health promotion and drug 
resistance prevention. 
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